Results 211 to 220 of about 330,463 (281)
Blind Equalization Based on Modified Third-Order Moment Algorithm for PAM-PPM Optical Signals in FSO Communication. [PDF]
Luo S, Li X.
europepmc +1 more source
Asymptotic properties of cross‐classified sampling designs
Abstract We investigate the family of cross‐classified sampling designs across an arbitrary number of dimensions. We introduce a variance decomposition that enables the derivation of general asymptotic properties for these designs and the development of straightforward and asymptotically unbiased variance estimators.
Jean Rubin, Guillaume Chauvet
wiley +1 more source
distQTL: distribution quantitative trait loci identification by population-scale single-cell data. [PDF]
Coulter A, Tong CY, Ni Y, Jiang Y.
europepmc +1 more source
On Convergent Diffusions: The Densities and the Conditioned Processes [PDF]
openaire +2 more sources
Asymptotic independence in more than two dimensions and its implications on risk management
Abstract In extreme value theory, the presence of asymptotic independence signifies that joint extreme events across multiple variables are unlikely. Although well understood in a bivariate context, the concept remains relatively unexplored when addressing the nuances of simultaneous occurrence of extremes in higher dimensions.
Bikramjit Das, Vicky Fasen‐Hartmann
wiley +1 more source
Accelerating multi-objective optimization of concrete thin shell structures using graph-constrained GANs and NSGA-II. [PDF]
Fang Z, Wang X, Sun Y, Adibhashimi MA.
europepmc +1 more source
Semiclassical inequalities for Dirichlet and Neumann Laplacians on convex domains
Abstract We are interested in inequalities that bound the Riesz means of the eigenvalues of the Dirichlet and Neumann Laplacians in terms of their semiclassical counterpart. We show that the classical inequalities of Berezin–Li–Yau and Kröger, valid for Riesz exponents γ≥1$\gamma \ge 1$, extend to certain values γ<1$\gamma <1$, provided the underlying ...
Rupert L. Frank, Simon Larson
wiley +1 more source
Sample size considerations for species co-occurrence models. [PDF]
Cowans A, Bigatà AB, Sutherland C.
europepmc +1 more source
Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III
Benjamin Rich +5 more
wiley +1 more source

